Antibacterial chelating agents with applications in industry and medicine: cellular metal restriction, membrane disruption, and synergism with antibiotics in <i>Escherichia coli, Pseudomonas aeruginosa, Serratia marcescens, Bacillus subtilis</i> , an
This study shows that all three chelators behave differently in restricting metal access and possess antibacterial properties that often act synergistically in combination, notably with other antimicrobials.
Authors
- Dominic J. Black (ORCID: https://orcid.org/0000-0003-0804-4860)
- Liane E. Jordan
- Róbert Pál (ORCID: https://orcid.org/0000-0002-0641-4218)
- Gary J. Sharples (ORCID: https://orcid.org/0000-0003-2495-0062)
- Erika R. Wallace
- Joy R. Paterson
- E. H. M. Wright
- Mary C. Moran (ORCID: https://orcid.org/0000-0002-6456-082X)
- Joshua M Wadsworth
- John Robert Ross
- Bethany L Hardman (ORCID: https://orcid.org/0009-0002-0819-763X)
- Laura A Clare
Institutions
- Durham University (GB)
- Procter & Gamble (United Kingdom) (GB)
- BD Biosciences (United States) (US)
Publication Details
- Journal
- Journal of Applied Microbiology
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1093/jambio/lxaf258
- Primary Topic
- Extraction and Separation Processes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Newcastle University
- Durham University
- Biotechnology and Biological Sciences Research Council